Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Diabetes|February 18, 2026
Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney DiseaseMadhura Bose, Muthukumar Mohan, Jun Okabe, et al.
Angewandte Chemie (International Ed. in English)|March 26, 2021
Genetic Engineering in Combination with Semi-Synthesis Leads to a New Route for Gram-Scale Production of the Immunosuppressive Natural Product Brasilicardin AAlma Botas, Michael Eitel, Paul N Schwarz, et al.
Diabetes|March 11, 2022
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive PathwaysJay C Jha, Aozhi Dai, Jessica Garzarella, et al.
Circulation|April 9, 2013
NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosisStephen P Gray, Elyse Di Marco, Jun Okabe, et al.
Diabetes|July 28, 2017
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic NephropathyJay C Jha, Claudine Banal, Jun Okabe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease developmentVicki Thallas-Bonke, Sih Min Tan, Runa S Lindblom, et al.
Contemporary Clinical Trials|November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerationsAnne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
Diabetes|September 15, 2018
Lipoxins Protect Against Inflammation in Diabetes-Associated AtherosclerosisEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Kidney International|December 9, 2023
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammationKarly C Sourris, Yi Ding, Scott S Maxwell, et al.
Plos Biology|September 30, 2010
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegenerationChristoph Kleinschnitz, Henrike Grund, Kirstin Wingler, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Diabetes|February 18, 2026
Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney DiseaseMadhura Bose, Muthukumar Mohan, Jun Okabe, et al.
Angewandte Chemie (International Ed. in English)|March 26, 2021
Genetic Engineering in Combination with Semi-Synthesis Leads to a New Route for Gram-Scale Production of the Immunosuppressive Natural Product Brasilicardin AAlma Botas, Michael Eitel, Paul N Schwarz, et al.
Diabetes|March 11, 2022
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive PathwaysJay C Jha, Aozhi Dai, Jessica Garzarella, et al.
Circulation|April 9, 2013
NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosisStephen P Gray, Elyse Di Marco, Jun Okabe, et al.
Diabetes|July 28, 2017
NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic NephropathyJay C Jha, Claudine Banal, Jun Okabe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease developmentVicki Thallas-Bonke, Sih Min Tan, Runa S Lindblom, et al.
Contemporary Clinical Trials|November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerationsAnne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
Diabetes|September 15, 2018
Lipoxins Protect Against Inflammation in Diabetes-Associated AtherosclerosisEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Kidney International|December 9, 2023
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammationKarly C Sourris, Yi Ding, Scott S Maxwell, et al.
Plos Biology|September 30, 2010
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegenerationChristoph Kleinschnitz, Henrike Grund, Kirstin Wingler, et al.
Pageof 19